vs
Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and ESSENTIAL PROPERTIES REALTY TRUST, INC. (EPRT). Click either name above to swap in a different company.
Axsome Therapeutics, Inc. is the larger business by last-quarter revenue ($196.0M vs $158.8M, roughly 1.2× ESSENTIAL PROPERTIES REALTY TRUST, INC.). ESSENTIAL PROPERTIES REALTY TRUST, INC. runs the higher net margin — 37.8% vs -14.6%, a 52.3% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs 22.8%). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 20.6%).
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
Essential Properties Realty Trust is a publicly traded real estate investment trust (REIT) that acquires, owns and manages a diversified portfolio of single-tenant net-leased commercial properties across the United States. Its assets primarily cover essential service-oriented sectors including casual dining, automotive services, medical clinics, early childhood education centers and light industrial facilities, with tenants mostly holding robust long-term operating track records.
AXSM vs EPRT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $196.0M | $158.8M |
| Net Profit | $-28.6M | $60.0M |
| Gross Margin | — | — |
| Operating Margin | -13.8% | 56.5% |
| Net Margin | -14.6% | 37.8% |
| Revenue YoY | 65.0% | 22.8% |
| Net Profit YoY | 61.9% | 6.5% |
| EPS (diluted) | $-0.55 | $0.28 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $158.8M | ||
| Q4 25 | $196.0M | $149.9M | ||
| Q3 25 | $171.0M | $144.9M | ||
| Q2 25 | $150.0M | $137.1M | ||
| Q1 25 | $121.5M | $129.4M | ||
| Q4 24 | $118.8M | $119.7M | ||
| Q3 24 | $104.8M | $117.1M | ||
| Q2 24 | $87.2M | $109.3M |
| Q1 26 | — | $60.0M | ||
| Q4 25 | $-28.6M | $68.1M | ||
| Q3 25 | $-47.2M | $65.6M | ||
| Q2 25 | $-48.0M | $63.2M | ||
| Q1 25 | $-59.4M | $56.1M | ||
| Q4 24 | $-74.9M | $55.4M | ||
| Q3 24 | $-64.6M | $49.1M | ||
| Q2 24 | $-79.3M | $51.5M |
| Q1 26 | — | 56.5% | ||
| Q4 25 | -13.8% | 65.9% | ||
| Q3 25 | -27.0% | 64.7% | ||
| Q2 25 | -24.5% | 64.1% | ||
| Q1 25 | -46.9% | 61.6% | ||
| Q4 24 | -61.1% | 66.1% | ||
| Q3 24 | -59.8% | 59.7% | ||
| Q2 24 | -89.5% | 61.1% |
| Q1 26 | — | 37.8% | ||
| Q4 25 | -14.6% | 45.4% | ||
| Q3 25 | -27.6% | 45.3% | ||
| Q2 25 | -32.0% | 46.1% | ||
| Q1 25 | -48.9% | 43.4% | ||
| Q4 24 | -63.1% | 46.3% | ||
| Q3 24 | -61.7% | 42.0% | ||
| Q2 24 | -91.0% | 47.1% |
| Q1 26 | — | $0.28 | ||
| Q4 25 | $-0.55 | $0.34 | ||
| Q3 25 | $-0.94 | $0.33 | ||
| Q2 25 | $-0.97 | $0.32 | ||
| Q1 25 | $-1.22 | $0.29 | ||
| Q4 24 | $-1.54 | $0.31 | ||
| Q3 24 | $-1.34 | $0.27 | ||
| Q2 24 | $-1.67 | $0.29 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $322.9M | $15.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $88.3M | $4.4B |
| Total Assets | $689.8M | $7.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $15.2M | ||
| Q4 25 | $322.9M | $60.2M | ||
| Q3 25 | $325.3M | $23.8M | ||
| Q2 25 | $303.0M | $20.8M | ||
| Q1 25 | $300.9M | $47.0M | ||
| Q4 24 | $315.4M | $40.7M | ||
| Q3 24 | $327.3M | $32.7M | ||
| Q2 24 | $315.7M | $23.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | $2.5B | ||
| Q3 25 | — | $2.6B | ||
| Q2 25 | — | $2.3B | ||
| Q1 25 | — | $2.1B | ||
| Q4 24 | — | $2.1B | ||
| Q3 24 | — | $2.2B | ||
| Q2 24 | — | $1.9B |
| Q1 26 | — | $4.4B | ||
| Q4 25 | $88.3M | $4.2B | ||
| Q3 25 | $73.7M | $3.8B | ||
| Q2 25 | $73.1M | $3.8B | ||
| Q1 25 | $53.2M | $3.8B | ||
| Q4 24 | $57.0M | $3.6B | ||
| Q3 24 | $92.9M | $3.2B | ||
| Q2 24 | $102.9M | $3.2B |
| Q1 26 | — | $7.2B | ||
| Q4 25 | $689.8M | $6.9B | ||
| Q3 25 | $669.3M | $6.6B | ||
| Q2 25 | $639.8M | $6.3B | ||
| Q1 25 | $596.7M | $6.1B | ||
| Q4 24 | $568.5M | $5.8B | ||
| Q3 24 | $561.5M | $5.5B | ||
| Q2 24 | $548.2M | $5.3B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.60× | ||
| Q3 25 | — | 0.69× | ||
| Q2 25 | — | 0.61× | ||
| Q1 25 | — | 0.56× | ||
| Q4 24 | — | 0.60× | ||
| Q3 24 | — | 0.69× | ||
| Q2 24 | — | 0.59× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.7M | — |
| Free Cash FlowOCF − Capex | $-18.7M | — |
| FCF MarginFCF / Revenue | -9.6% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-93.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-18.7M | $381.1M | ||
| Q3 25 | $1.0M | $99.0M | ||
| Q2 25 | $-32.4M | $99.8M | ||
| Q1 25 | $-43.4M | $77.2M | ||
| Q4 24 | $-26.2M | $308.5M | ||
| Q3 24 | $-18.6M | $73.5M | ||
| Q2 24 | $-30.1M | $81.1M |
| Q1 26 | — | — | ||
| Q4 25 | $-18.7M | — | ||
| Q3 25 | $988.0K | — | ||
| Q2 25 | $-32.4M | — | ||
| Q1 25 | $-43.7M | — | ||
| Q4 24 | $-26.2M | — | ||
| Q3 24 | $-18.7M | — | ||
| Q2 24 | $-30.2M | — |
| Q1 26 | — | — | ||
| Q4 25 | -9.6% | — | ||
| Q3 25 | 0.6% | — | ||
| Q2 25 | -21.6% | — | ||
| Q1 25 | -36.0% | — | ||
| Q4 24 | -22.1% | — | ||
| Q3 24 | -17.9% | — | ||
| Q2 24 | -34.6% | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.1% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 5.60× | ||
| Q3 25 | — | 1.51× | ||
| Q2 25 | — | 1.58× | ||
| Q1 25 | — | 1.38× | ||
| Q4 24 | — | 5.57× | ||
| Q3 24 | — | 1.50× | ||
| Q2 24 | — | 1.57× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXSM
Segment breakdown not available.
EPRT
| Rental revenue 1,2 | $149.4M | 94% |
| Other | $8.6M | 5% |
| Other revenue | $779.0K | 0% |
